{
    "nctId": "NCT02609724",
    "briefTitle": "Effectiveness of Fluoroscopy-guided MLD for Treatment of BCRL",
    "officialTitle": "Effectiveness of Fluoroscopy-guided Manual Lymph Drainage (MLD) Versus Traditional MLD or Placebo MLD, as Part of Decongestive Lymphatic Therapy, for the Treatment of Breast Cancer-related Lymphoedema (BCRL): a Randomised Controlled Trial",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasm, Lymphedema",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 194,
    "primaryOutcomeMeasure": "Lymphoedema Volume at the Level of the Arm/ Hand",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \\>18y (since the treatment with MLD and the investigation using ICG is not dangerous for pregnant women, women with child bearing age are included)\n* Women/ men with breast cancer-related lymphoedema\n* Chronic lymphoedema (\\>3 months present), stage I to IIb\n* At least 5% difference between both arms and/ or hands, adjusted for dominance\n* Written informed consent obtained\n\nExclusion Criteria:\n\n* Allergy for iodine, sodiumiodine, ICG\n* Increased activity of the thyroid gland; benign tumors of the thyroid gland\n* Age \\<18y\n* Oedema of the upper limb from other causes\n* Active metastasis of the cancer\n* Surgery of the lymphatic system in the past (lymph node transplantation, lymphovenous shunt)\n* Cannot participate during the entire study period\n* Mentally or physically unable to participate in the study",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}